Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

In this episode, I talked with Myriam Cherif, former Regional Medical Lead for Oncology & Emerging Markets at GSK and founder of Kalyx Medical—a consultancy focused on Medical Affairs strategy, mentoring, and AI training.

I invited Myriam to join me here because she posts some of the most insightful and practical content about what life is really like as a Medical Affairs professional. She shares her journey from academia to pharma, and what it really takes to succeed in Medical Affairs without losing your sense of purpose. She opens up about the early days at Novartis, the steep transition from the lab to corporate life, and the practical lessons she learned through trial and error—most especially the KOL meeting that didn’t go as planned.

She also shares the turning point that came when her role at GSK was made redundant, how that moment became the spark behind founding Kalyx Medical, and why she now helps MSLs and Medical Leads use AI with intention, and not as a gimmick. Along the way, she reflects on mentorship, resilience, and how to stand out in an industry that tests both your patience and adaptability.

(Find out more in the episode.)

Here’s What You’re In For

  1. Why mentorship can make or break your first MSL year
  2. The “so what” factor that makes a CV stand out
  3. How AI can help MSLs read smarter, not harder

Timestamps

01:15 – From PhD in molecular biology to Medical Affairs

03:07 – The reality behind the MSL role

05:30 – Starting at Novartis and feeling out of depth

06:52 – Her first KOL meeting—and what went wrong

08:08 – Why mentorship changes everything

10:17 – How long it took to land her first MSL role

15:34 – Turning objections into opportunities

22:42 – From GSK restructure to starting Kalyx Medical

25:26 – Two big mistakes companies make with AI

28:37 – How AI gives MSLs a competitive edge


About Myriam

Dr. Myriam Cherif is the former Regional Medical Lead – Oncology, Emerging Markets at GSK and the Founder of Kalyx Medical, a consultancy focused on medical affairs strategy and AI training. With over 14 years of experience in the pharmaceutical industry, Myriam has worked across a wide range of therapy areas, including cardiovascular, immunology, and oncology, and held leadership roles spanning the UK and emerging markets.

At GSK, she led medical strategy and scientific engagement across diverse regions, ensuring compliance and excellence in oncology communication. Through Kalyx Medical, Myriam also supports biotech and pharma companies by enhancing their medical affairs capabilities and preparing teams for the evolving landscape of AI-driven drug development and engagement.

Connect with Myriam

  1. LinkedIn: https://www.linkedin.com/in/myriam-cherif-phd-977a911/
  2. Kalyx Medical: https://www.linkedin.com/company/kalyx-medical/about/


About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment, I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

  1. LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
  2. Website: https://www.discera-search.com/



Opinions and comments expressed by the guest do not represent the company and are fully their own.

Avsnitt(67)

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Mars 42min

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Mars 29min

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at...

24 Feb 31min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Jan 35min

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

In this episode, I talked with Prof. Dr. med. Markus Kosch, Head of Oncology Europe and Canada at Daiichi Sankyo Europe, about what it really means to lead with empathy, perseverance, and purpose in t...

19 Jan 35min

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

In this episode, I talked with Sven Van den Berghe, CEO of Pantera, about his 25+ years in nuclear physics, from his early days at the Belgian Nuclear Research Center to stepping into the high-stakes ...

17 Nov 202527min

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

In this episode, I talked with Catello Somma, Partner at Seroba, to learn about his nonlinear journey from academia and biopharma into venture capital—and the realities behind building funds, backing ...

10 Nov 202521min

Populärt inom Business & ekonomi

framgangspodden
varvet
rss-jossan-nina
rss-svart-marknad
rss-borsens-finest
badfluence
avanzapodden
uppgang-och-fall
svd-tech-brief
bathina-en-podcast
fill-or-kill
lastbilspodden
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
tabberaset
rss-inga-dumma-fragor-om-pengar
24fragor
kapitalet-en-podd-om-ekonomi
rikatillsammans-om-privatekonomi-rikedom-i-livet
borsmorgon